One lab, two firms, many Possibilities: On R&D outsourcing in the biopharmaceutical industry

Bruno Versaevel

Post-Print from HAL

Date: 2018-05-18
References: Add references at CitEc
Citations:

Published in 19th European Health Economics Workhop, PSE (Paris School of Economics), May 2018, Paris, France

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
Journal Article: One lab, two firms, many possibilities: On R&D outsourcing in the biopharmaceutical industry (2019)
Working Paper: One Lab, Two Firms, Many Possibilities: on R&D outsourcing in the biopharmaceutical industry (2019)
Working Paper: One lab, two firms, many Possibilities: On R&D outsourcing in the biopharmaceutical industry (2018)
Working Paper: One Lab, Two Firms, Many Possibilities: on R&D outsourcing in the biopharmaceutical industry (2017)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:halshs-01960435

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().